Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy Subjects
NCT02187536 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2014-07-11
Summary
To assess the pharmacokinetics of simvastatin and simvastatin acid with/without concomitant administration of telmisartan
Conditions
- Healthy
Interventions
- DRUG
-
Telmisartan
- DRUG
-
Simvastatin
- DRUG
-
Telmisartan placebo
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-04-30
- Primary Completion
- 2000-05-31
More Related Trials
-
A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants
NCT05933187 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers
NCT03072056 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect Single and Multiple Oral Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Amitriptyline and Nortriptyline in Healthy Male and Female Subjects
NCT02256878 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)
NCT06442436 ·Status: RECRUITING ·Phase: PHASE1
-
Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects
NCT02264054 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy Men
NCT04123288 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects
NCT00854659 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects
NCT00418756 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate
NCT00369304 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects
NCT03198624 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04249284 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants
NCT01106469 ·Status: COMPLETED ·Phase: PHASE1
-
Explore the Performance of IntelliCap.
NCT02025348 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants
NCT02982707 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-B
NCT01125657 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Assess the Pharmacokinetics, Safety, and Tolerability of ACT-129968 in Healthy Subjects
NCT01877629 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.
NCT04663464 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)
NCT00413634 ·Status: COMPLETED ·Phase: PHASE2
-
PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function
NCT01429337 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Bosentan on the Pharmacokinetics of Nintedanib
NCT02667704 ·Status: COMPLETED ·Phase: PHASE1
-
Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults
NCT03849287 ·Status: UNKNOWN ·Phase: PHASE1
-
Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects
NCT01976572 ·Status: COMPLETED ·Phase: PHASE1
-
A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions
NCT00773630 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function
NCT00418626 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety Profile of CKD-333
NCT03659149 ·Status: COMPLETED ·Phase: PHASE1